Cargando…
Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion()
Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041268/ http://dx.doi.org/10.1016/j.rcreue.2020.05.009 |
_version_ | 1783677908081967104 |
---|---|
author | López, Josué-Guillermo Camacho-Barbosa, Jhyld-Carolaind Felipe-Díaz, Oscar-Jair Rojas-Zuleta, Wilmer-Gerardo Ballesteros, Jesús-Giovanny Navarro-Mendoza, Erika-Paola Giraldo Herrera, Claudia-Lucía Giraldo-Bustos, Rodrigo Padilla-Tovar, Lácides Duque-Zapata, Natalia Orozco González, Catalina López-Mora, María-José Donado, Jorge-Hernando |
author_facet | López, Josué-Guillermo Camacho-Barbosa, Jhyld-Carolaind Felipe-Díaz, Oscar-Jair Rojas-Zuleta, Wilmer-Gerardo Ballesteros, Jesús-Giovanny Navarro-Mendoza, Erika-Paola Giraldo Herrera, Claudia-Lucía Giraldo-Bustos, Rodrigo Padilla-Tovar, Lácides Duque-Zapata, Natalia Orozco González, Catalina López-Mora, María-José Donado, Jorge-Hernando |
author_sort | López, Josué-Guillermo |
collection | PubMed |
description | Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-8041268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80412682021-04-13 Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() López, Josué-Guillermo Camacho-Barbosa, Jhyld-Carolaind Felipe-Díaz, Oscar-Jair Rojas-Zuleta, Wilmer-Gerardo Ballesteros, Jesús-Giovanny Navarro-Mendoza, Erika-Paola Giraldo Herrera, Claudia-Lucía Giraldo-Bustos, Rodrigo Padilla-Tovar, Lácides Duque-Zapata, Natalia Orozco González, Catalina López-Mora, María-José Donado, Jorge-Hernando Revista Colombiana de Reumatología (English Edition) Reflexion Article Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic. Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2021 2021-04-12 /pmc/articles/PMC8041268/ http://dx.doi.org/10.1016/j.rcreue.2020.05.009 Text en © 2020 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Reflexion Article López, Josué-Guillermo Camacho-Barbosa, Jhyld-Carolaind Felipe-Díaz, Oscar-Jair Rojas-Zuleta, Wilmer-Gerardo Ballesteros, Jesús-Giovanny Navarro-Mendoza, Erika-Paola Giraldo Herrera, Claudia-Lucía Giraldo-Bustos, Rodrigo Padilla-Tovar, Lácides Duque-Zapata, Natalia Orozco González, Catalina López-Mora, María-José Donado, Jorge-Hernando Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() |
title | Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() |
title_full | Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() |
title_fullStr | Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() |
title_full_unstemmed | Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() |
title_short | Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion() |
title_sort | recommendations for rheumatologists on pharmacological management during the covid-19 health emergency: expert group opinion() |
topic | Reflexion Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041268/ http://dx.doi.org/10.1016/j.rcreue.2020.05.009 |
work_keys_str_mv | AT lopezjosueguillermo recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT camachobarbosajhyldcarolaind recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT felipediazoscarjair recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT rojaszuletawilmergerardo recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT ballesterosjesusgiovanny recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT navarromendozaerikapaola recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT giraldoherreraclaudialucia recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT giraldobustosrodrigo recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT padillatovarlacides recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT duquezapatanatalia recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT orozcogonzalezcatalina recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT lopezmoramariajose recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion AT donadojorgehernando recommendationsforrheumatologistsonpharmacologicalmanagementduringthecovid19healthemergencyexpertgroupopinion |